Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Alder Biopharma (ALDR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Best Relative Performance in the Biotechnology Industry Detected in Shares of Immunogen Inc (IMGN, MDXG, PGNX, ALDR, AKBA)

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

MDXG : 17.09 (+2.09%)
PGNX : 5.93 (+6.65%)
ALDR : 9.55 (-1.55%)
AKBA : 15.36 (+1.32%)
IMGN : 6.10 (-2.87%)
Downtrend Call Working As Alder Biopharmac Stock Falls 39.7% (ALDR)

SmarTrend identified a Downtrend for Alder Biopharmac (NASDAQ:ALDR) on June 27th, 2017 at $14.67. In approximately 1 month, Alder Biopharmac has returned 39.69% as of today's recent price of $8.85.

ALDR : 9.55 (-1.55%)
Alder BioPharmaceuticals(R) to Host Conference Call to Discuss Second Quarter 2017 Financial and Operating Results

Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced that it will report its second quarter 2017 financial...

ALDR : 9.55 (-1.55%)
Vertex Pharm has the Best Relative Performance in the Biotechnology Industry (VRTX, OPK, TSRO, ONCE, ALDR)

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

ONCE : 79.00 (+1.07%)
ALDR : 9.55 (-1.55%)
VRTX : 151.53 (-0.78%)
OPK : 6.05 (-0.66%)
TSRO : 112.37 (-1.43%)
Downtrend Call Working As Alder Biopharmac Stock Falls 18.2% (ALDR)

SmarTrend identified a Downtrend for Alder Biopharmac (NASDAQ:ALDR) on June 27th, 2017 at $14.67. In approximately 3 weeks, Alder Biopharmac has returned 18.23% as of today's recent price of $12.00.

ALDR : 9.55 (-1.55%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (ALDR, HRTX, ADXS, BLCM, CARA)

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

ADXS : 6.16 (+0.82%)
CARA : 14.22 (+1.14%)
ALDR : 9.55 (-1.55%)
BLCM : 8.07 (+4.81%)
HRTX : 15.60 (+1.30%)
Today's Research Reports on Stocks to Watch: Alder BioPharmaceuticals Inc. and Verastem Inc.

NEW YORK, NY / ACCESSWIRE / July 13, 2017 / U.S. markets rose Wednesday as investors reacted positively to Federal Reserve Chairwoman Janet Yellen's congressional testimony. The Dow Jones Industrial Average...

ALDR : 9.55 (-1.55%)
VSTM : 3.22 (+1.90%)
Alder BioPharmaceuticals, Inc. Prices Public Offering of Common Stock

Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing its solely-owned pivotal-stage product candidate eptinezumab as the only anti-CGRP monoclonal antibody...

ALDR : 9.55 (-1.55%)
Downtrend Call Working As Alder Biopharmac Stock Falls 16.9% (ALDR)

SmarTrend identified a Downtrend for Alder Biopharmac (NASDAQ:ALDR) on June 27th, 2017 at $14.67. In approximately 2 weeks, Alder Biopharmac has returned 16.87% as of today's recent price of $12.20.

ALDR : 9.55 (-1.55%)
Alder's Shares Dip Despite Positive Migraine Trial Results

Alder Biopharmaceuticals, Inc.'s (ALDR) shares plummeted almost 28% despite the announcement of positive top line results from phase III study, evaluating its lead pipeline candidate eptinezumab for prevention...

ALDR : 9.55 (-1.55%)
LLY : 81.70 (-0.01%)
TEVA : 17.42 (-3.06%)
AMGN : 172.23 (+1.29%)
Look for Shares of Alder Biopharmac to Potentially Rebound after Yesterday's 22.19% Sell Off

Alder Biopharmac (NASDAQ:ALDR) traded in a range yesterday that spanned from a low of $13.80 to a high of $15.90. Yesterday, the shares fell 22.2%, which took the trading range below the 3-day low of...

ALDR : 9.55 (-1.55%)
Implied Volatility Surging for Alder Biopharmaceuticals (ALDR) Stock Options

Alder Biopharmaceuticals (ALDR) needs Investors to pay close attention to the stock based on moves in the options market lately.

ALDR : 9.55 (-1.55%)
Alder BioPharmaceuticals Announces Positive Eptinezumab Phase 3 Results for Prevention of Frequent Episodic Migraine

-- Pivotal PROMISE 1 top-line results show eptinezumab met primary and key secondary endpoints --

ALDR : 9.55 (-1.55%)
Global Vasculitis Treatment Market to Grow at a CAGR of 4.2% 2017-2021: Key Vendors are Bristol-Myers Squibb, Celgene, F. Hoffmann-La Roche & GlaxoSmithKline

Research and Markets has announced the addition of the "Global Vasculitis Treatment Market 2017-2021" report to their offering. The global vasculitis treatment market to grow at a CAGR of 4.20 % during...

ALDR : 9.55 (-1.55%)
ALPMF : 12.5200 (-0.63%)
ATRS : 3.05 (+1.33%)
ACOR : 21.40 (+0.94%)
CELGZ : 1.22 (+2.52%)
GSK : 39.26 (+0.80%)
BMY : 57.09 (-1.35%)
Biotech Stock Performance Review -- Alder Biopharma, Ardelyx, Bellerophon Therapeutics, and Corbus Pharma

If you want a Stock Review on ALDR, ARDX, BLPH or CRBP then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Today's research on DailyStockTracker.com...

CRBP : 6.03 (+0.93%)
ALDR : 9.55 (-1.55%)
ARDX : 4.85 (+3.19%)
BLPH : 1.12 (+1.82%)
Alder BioPharmaceuticals (ALDR) Looks Good: Stock Adds 10.7% in Session

Alder BioPharmaceuticals' (ALDR) nearly 11% price rise in the last session increases the inquisitiveness for the stock. Read on to know more.

VVUS : 1.01 (unch)
ALDR : 9.55 (-1.55%)
Lilly's Migraine Drug Phase III Trials Meet Primary Endpoint

Eli Lilly and Company (LLY) recently announced that its migraine candidate, galcanezumab, met primary endpoint in phase III studies

ALDR : 9.55 (-1.55%)
LLY : 81.70 (-0.01%)
TEVA : 17.42 (-3.06%)
AMGN : 172.23 (+1.29%)
Alder BioPharmaceuticals(R) to Present at the Bank of America Merrill Lynch 2017 Health Care Conference

Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced that it will webcast its presentation at the upcoming...

ALDR : 9.55 (-1.55%)
Research Reports Initiation on Biotech Stocks -- Egalet, Argos Therapeutics, Alder Biopharma, and Anavex Life Sciences

On Wednesday, May 03, 2017, US markets saw broad based losses with eight out of nine sectors finishing the trading sessions in red. Major US indices were mixed at the close of yesterday's session. The...

ARGS : 0.22 (unch)
ALDR : 9.55 (-1.55%)
AVXL : 3.86 (-3.02%)
EGLT : 1.12 (+1.82%)
Alder BioPharmaceuticals Presents Additional Data from Eptinezumab Development Program at 69th Annual American Academy of Neurology Meeting

- Eptinezumab rational design results in differentiated clinical profile for migraine prevention therapy -

ALDR : 9.55 (-1.55%)

Van Meerten Stock Picks

5 Mid Cap Picks
Today I wanted to find 5 Mid Cap Stocks with current momentum, so I used Barchart to sort the S&P 400 Mid Cap Index stocks first for the highest Weighted Alpha, then again for technical buy signal s of 80% or more.
CGNX +0.15 , IPGP +1.35 , NVR -3.87 , TTWO +1.42 , AAN +0.14
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Sep E-mini S&Ps ( ESU17 +0.17%) this morning are up +0.21% and European stocks are up +0.87% on economic optimism after Eurozone Q2 GDP rose at a +0.6% q/q pace, right on expectations. In addition, the UK labor... Read More

Chart of the Day

Chart of the Day

CryoPort (CYRX) is the Barchart Chart of the Day.  The specialty shipping company has a Trend Spotter buy signal, a Weighted Alpha of 430.32+ and gained 279.50% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures are trading fractionally higher this morning. They ended Tuesday trade with most contacts 4 1/2 to 8 cents in the red, on improved crop condition ratings. Maturity is still lagging. The USDA Crop Progress report showed that 16% of the ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.